for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Cantel Medical Corp.

CMD.N

Latest Trade

70.95USD

Change

-1.86(-2.55%)

Volume

16,078

Today's Range

70.28

 - 

72.84

52 Week Range

63.52

 - 

93.77

As of on the New York Stock Exchange ∙ Minimum 15 minute delay

Pricing

Previous Close
72.81
Open
72.84
Volume
16,078
3M AVG Volume
5.66
Today's High
72.84
Today's Low
70.28
52 Week High
93.77
52 Week Low
63.52
Shares Out (MIL)
42.52
Market Cap (MIL)
3,096.06
Forward P/E
26.08
Dividend (Yield %)
0.27

Next Event

Q1 2020 Cantel Medical Corp Earnings Release

Latest Developments

More

Cantel Medical Reports Q4 Non-GAAP Earnings Per Share $0.63

Cantel To Acquire Hu-Friedy For $725 Million

Cantel Medical Reports Q3 Earnings Per Share $0.20

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About Cantel Medical Corp.

Cantel Medical Corp. is a provider of infection prevention products and services in the healthcare market. The Company's operating segments include Endoscopy; Water Purification and Filtration; Healthcare Disposables, and Dialysis. Its Endoscopy segment includes medical device reprocessing systems, disinfectants, detergents and other supplies. The Company's Water Purification and Filtration segment includes water purification equipment and services, filtration and separation products, and disinfectant, sterilization and decontamination products and services. Its Healthcare Disposables segment includes single-use, infection prevention and control healthcare products. The Company's Dialysis segment includes medical device reprocessing systems, sterilants/disinfectants, dialysate concentrates and other supplies for renal dialysis. The Company offers a range of filters utilizing hollow fiber membrane technology.

Industry

Medical Equipment & Supplies

Contact Info

150 Clove Rd

+1.973.8907220

http://www.cantelmedical.com/

Executive Leadership

Charles M. Diker

Chairman of the Board

George L. Fotiades

President, Chief Executive Officer, Director

Shaun M. Blakeman

Chief Financial Officer, Senior Vice President

Peter G. Clifford

Chief Operating Officer, Executive Vice President

Jean Casnerhas

Chief Human Resource Officer, Senior Vice President

Key Stats

2.50 mean rating - 4 analysts
Sell
Hold
Buy
Revenue (MM, USD)

2017

0.8K

2018

0.9K

2019

0.9K

2020(E)

1.2K
EPS (USD)

2017

2.080

2018

2.510

2019

2.370

2020(E)

2.792
Price To Earnings (TTM)
53.67
Price To Sales (TTM)
3.37
Price To Book (MRQ)
4.60
Price To Cash Flow (TTM)
31.27
Total Debt To Equity (MRQ)
34.90
LT Debt To Equity (MRQ)
33.38
Return on Investment (TTM)
6.48
Return on Equity (TTM)
5.57

Latest News

Latest News

BRIEF-Cantel Medical Receives FDA 510(K) Clearance To Market Advantage Plus® Pass-Thru Automated Endoscope Reprocessor

* CANTEL MEDICAL RECEIVES FDA 510(K) CLEARANCE TO MARKET ADVANTAGE PLUS® PASS-THRU AUTOMATED ENDOSCOPE REPROCESSOR Source text for Eikon: Further company coverage:

BRIEF-Cantel Medical Acquires Aexis Medical

* CANTEL MEDICAL CORP - TOTAL DEAL CONSIDERATION WAS $24.8 MILLION

BRIEF-Cantel Medical Q2 Non-GAAP Earnings Per Share $0.71

* CANTEL MEDICAL REPORTS RECORD FINANCIAL RESULTS FOR ITS SECOND QUARTER FISCAL YEAR 2018

BRIEF-Cantel Medical Corp Chairman Charles Diker Reports Sale Of 10,000 Shares

* CANTEL MEDICAL CORP CHAIRMAN CHARLES DIKER REPORTS OPEN MARKET SALE OF 10,000 SHARES OF CO'S COMMON STOCK ON JAN 16 AT $110.96 PER SHARE - SEC FILING Source text : ( http://bit.ly/2Bbo21u ) Further company coverage:

BRIEF-Cantel Medical Reports Record Financial Results For Q1 Fiscal Year 2018

* Q1 EARNINGS PER SHARE VIEW $0.54 -- THOMSON REUTERS I/B/E/S Source text for Eikon: Further company coverage:

BRIEF-Cantel Medical appoints Peter Pronovost to board

* On Nov. 1, 2017, board appointed Peter Pronovost as member of board, expanding board from nine members to ten members - SEC filing Source text for Eikon: (http://bit.ly/2z72pTh) Further company coverage:

BRIEF-Cantel Medical Q4 non-GAAP earnings per share $0.54

* Cantel Medical reports record financial results for the fourth quarter ended July 31, 2017

BRIEF-Cantel Medical to acquire BHT Group in Germany

* Cantel Medical Corp - deal for cash purchase price of approximately $60.8 million on a cash-free and debt- free basis

BRIEF-Cantel Medical Q3 non-GAAP earnings per share $0.51

* Cantel Medical reports financial results for the third quarter ended April 30, 2017

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up